Advertisement

Sat, 21 Nov, 2026

Read Life Mag

Today’s Game

Daily Snakes and Ladders

12 mins play

Play now

Services & Opportunities

Latest news today on Fidson Health Care Plc

Fidson Health Care Plc
Health

Firms begin study on chewable albendazole formulation

2 years ago

Deputy Managing Director, Fidson Healthcare Plc., Mr. Biola Adebayo (left); Director, Clinical Research & Drug Development Liddie BE Ltd; Mr. Bolakale Ayinde; Chief Nurse, Liddie BE Ltd; Mrs. Osayuwa Oyebola Wuraola; Founder/Managing Director, Fidson Healthcare Plc, Dr. Fidelis Ayebae; Chief Operating Officer, Liddie BE Ltd, Mr. Wale Ogunsola; and Strategy and Marketing Director, Fidson Healthcare Plc. Mr. Olugbenga Olayeye, at the announcement of the Bio-Equivalent study for Albendazole in Lagos Nigeria.

Fidson Health Care Plc has partnered with a clinical research organisation, Liddie BE Ltd to conduct a Bioequivalence (BE) study on their chewable formulation of Albendazole tablets.

Advertisement